-The Hindu Year 2015 will be crucial as shale oil firms begin to feel the pinch of low prices Are falling oil prices good or bad for the global economy? And how do they work for India? Till recently these questions were no-brainers. Cheaper oil is obviously good for the global economy; for an energy-intensive economy such as India's, which also depends on imported oil for meeting four-fifths of its needs, a...

-The Telegraph New Delhi: The Narendra Modi government may introduce a health cess to fund free health care services and launch seven preventive campaigns to curb illnesses under a draft health policy unveiled today. Some analysts, however, said the draft of the National Health Policy 2015 lacked emphasis on regulating India's private health industry, necessary to curb the high cost of health care. The draft says the government has the "political will" to...

-Livemint The development economist on the Modi government's initiatives and his stand on them, and MGNREGS The Narendra Modi-led government should consider replacing inefficient subsidies with a basic monthly income for all citizens, says Pranab Bardhan , emeritus professor of economics at the University of California at Berkeley. Bardhan, who recently sparred with economists Jagdish Bhagwati and Arvind Panagariya in a debate over the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS),...

-The Indian Express The World Universal Health Coverage Day, observed on December 12, builds on growing global momentum towards introducing universal health coverage (UHC) in national health plans and reinforces the case for including UHC as a prominent sustainable development goal to be adopted by the UN next year. India proposes to implement a programme of national health assurance, which embraces the principles of UHC. It is expected that the government...

-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin...